Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists

ChemMedChem - United Kingdom
doi 10.1002/cmdc.201900021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2011English

Small-Molecule Inhibitors of Protein-Protein Interactions

Current Topics in Microbiology and Immunology
AllergyImmunologyMicrobiology
2011English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

In Silicoscreening Identified Novel Small-Molecule Antagonists of PAC1 Receptor

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Identification of Small Molecule Inhibitors of Interleukin-18

Scientific Reports
Multidisciplinary
2017English

Novel Small-Molecule Inhibitors of BCL-Xl to Treat Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

Discovery and Characterization of Small Molecule Rac1 Inhibitors

Oncotarget
Oncology
2017English

Small Molecule Inhibitors of HCV Replication From Pomegranate

Scientific Reports
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy